LYCA Stock: Price, Earnings History and SEC Filings
Lycia Therapeutics, Inc. (LYCA) last traded at $26.40, down 4.80% on the latest session and down 12.0% over the past month.
$26.40 -4.80%
1 month-12.00%
52-week high$36.49
52-week low$22.19
Volume202,451
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
LYCA earnings history
Earnings history is not available right now.
Latest SEC filings for LYCA
SEC filing data is not available right now. You can search for LYCA on SEC EDGAR.
LYCA news
- Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesOct 26, 2026 · finance.yahoo.com
- Lycia Therapeutics CFO Amy Bachrodt Receives 399,746 Stock Options at $3.70 Pre-IPOOct 26, 2026 · kalkinemedia.com
- Lycia Therapeutics CEO Aetna Wun Trombley Receives 443,586 Stock Options at $3.70 Exercise PriceOct 26, 2026 · kalkinemedia.com
- Lycia Therapeutics (LYCA) Jumps After IPO With Valuation Questions Now Front And CenterOct 26, 2026 · finance.yahoo.com
- Forget Anthropic: Biotech Is Quietly Dominating the IPO SphereOct 24, 2026 · finance.yahoo.com
- Lycia Therapeutics surges in debut following upsized $317.5M IPOOct 23, 2026 · finance.yahoo.com
- Lycia Therapeutics Announces Pricing of Upsized Initial Public OfferingOct 22, 2026 · markets.businessinsider.com
- Protein degrader drug developer Lycia seeks $228M in U.S. IPOOct 20, 2026 · seekingalpha.com
About Lycia Therapeutics, Inc.
Lycia Therapeutics, Inc. (LYCA) is a US-listed public company on Nasdaq.